<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01007851</url>
  </required_header>
  <id_info>
    <org_study_id>AH-48/07</org_study_id>
    <nct_id>NCT01007851</nct_id>
  </id_info>
  <brief_title>Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>V.K.V. American Hospital, Istanbul</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>V.K.V. American Hospital, Istanbul</source>
  <brief_summary>
    <textblock>
      GnRH agonist administration in the luteal phase was reported to beneficially affect clinical
      outcome of ICSI-ET cycles. This randomized controlled trial evaluates the effect of a single
      dose GnRH agonist administered in the luteal phase on the outcome of ICSI - ET cycles
      stimulated with the fixed GnRH antagonist protocol. Women undergoing embryo transfer
      following controlled ovarian hyperstimulation with a fixed GnRH antagonist protocol were
      included. In addition to routine luteal phase support with progesterone women were randomized
      to receive a single dose of GnRH agonist or placebo on the sixth day after ICSI.Ongoing
      pregnancy rate was the primary outcome measure.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lower than anticipated recruitment
  </why_stopped>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Ongoing pregnancy beyond 20th gestational week</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical pregnancy rate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Embryo implantation rate</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>GnRH agonist</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triptorelin acetate</intervention_name>
    <description>single dose of 0.1 mg triptorelin subcutaneous injection on the 3rd day after embryo transfer</description>
    <arm_group_label>GnRH agonist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NaCl %0.9</intervention_name>
    <description>0.1 ml sterile saline sc injection 3 days after embryo transfer</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing embryo transfer following controlled ovarian hyperstimulation with a
             fixed GnRH antagonist protocol, oocyte pick-up and ICSI.

          -  Embryo transfer performed on day 3

        Exclusion Criteria:

          -  Participation in another trial that was being conducted in our unit at the same time.

          -  Preimplantation genetic screening cycles.

          -  Day 5 embryo transfers.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>American Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34365</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2009</study_first_submitted>
  <study_first_submitted_qc>November 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2009</study_first_posted>
  <last_update_submitted>November 3, 2009</last_update_submitted>
  <last_update_submitted_qc>November 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2009</last_update_posted>
  <keyword>GnRH agonist</keyword>
  <keyword>GnRH antagonist</keyword>
  <keyword>IVF</keyword>
  <keyword>ICSI</keyword>
  <keyword>assisted reproduction</keyword>
  <keyword>luteal phase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triptorelin Pamoate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

